Ink-spiring innovations: 3D bioprinting skin models for disease discovery

References

• 1. Zhang YS, Haghiashtiani G, Hübscher T et al. 3D extrusion bioprinting. Nat. Rev. Methods Primer. 1(1), 75 (2021).
  CASGoogle Scholar
• 2. Lai-Cheong JE, McGrath JA. Structure and function of skin, hair and nails. Medicine (Baltimore). 41(6), 317–320 (2013).
  Google Scholar
• 3. Weidinger S, Beck LA, Bieber T, Kabashima K, Irvine AD. Atopic dermatitis. Nat. Rev. Dis. Primer 4(1), 1 (2018).
  MedlineGoogle Scholar
• 4. Sviland L, Dickinson AM. A human skin explant model for predicting graft-versus-host disease following bone marrow transplantation. J. Clin. Pathol. 52(12), 910–913 (1999).
  Medline CASGoogle Scholar
• 5. Liu X, Michael S, Bharti K, Ferrer M, Song MJ. A biofabricated vascularized skin model of atopic dermatitis for preclinical studies. Biofabrication. 12(3), 035002 (2020).
  Medline CASGoogle Scholar
• 6. Bieber T, Paller AS, Kabashima K et al. Atopic dermatitis: pathomechanisms and lessons learned from novel systemic therapeutic options. J. Eur. Acad. Dermatol. Venereol. 36(9), 1432–1449 (2022).
  Medline CASGoogle Scholar
• 7. Hennies HC, Poumay Y. Skin Disease Models In Vitro and Inflammatory Mechanisms: Predictability for Drug Development. In: Organotypic Models in Drug Development. Vol 265, Handbook of Experimental Pharmacology. Schäfer-Korting MStuchi Maria-Engler SLandsiedel R (Eds). Springer International Publishing, 187–218 (2021).
  Google Scholar
• 8. Adler S, Basketter D, Creton S et al. Alternative (non-animal) methods for cosmetics testing: current status and future prospects – 2010. Arch. Toxicol. 85(5), 367–485 (2011).
  Medline CASGoogle Scholar
• 9. Sun S, Jin L, Zheng Y, Zhu J. Modeling human HSV infection via a vascularized immune-competent skin-on-chip platform. Nat. Commun. 13(1), 5481 (2022).
  Medline CASGoogle Scholar
• 10. Moon S, Kim DH, Shin JU. In Vitro Models Mimicking Immune Response in the Skin. Yonsei Med. J. 62(11), 969 (2021).
  Medline CASGoogle Scholar
• 11. Ozbolat IT, Hospodiuk M. Current advances and future perspectives in extrusion-based bioprinting. Biomaterials 76, 321–343 (2016).
  Medline CASGoogle Scholar
• 12. Dickinson AM, Cavet J, Cullup H, Wang XN, Sviland L, Middleton PG. GvHD risk assessment in hematopoietic stem cell transplantation: role of cytokine gene polymorphisms and an in vitro human skin explant model. Hum. Immunol. 62(11), 1266–1276 (2001).
  Medline CASGoogle Scholar
• 13. Kumar S, Mohammadpour H, Cao X. Targeting Cytokines in GVHD Therapy. J. Immunol. Res. Ther. 2(1), 90–99 (2017).
  MedlineGoogle Scholar
• 14. Petersdorf EW. Role of major histocompatibility complex variation in graft-versus-host disease after hematopoietic cell transplantation. F1000Res. 6, 617 (2017).
  MedlineGoogle Scholar
• 15. Shopova D, Yaneva A, Bakova D et al. (Bio)printing in Personalized Medicine-Opportunities and Potential Benefits. Bioeng. Basel Switz. 10(3), 287 (2023).
  MedlineGoogle Scholar